Use of electronic cigarettes and self-reported COPD diagnosis in adults.
Electronic cigarette use (vaping) has increased in recent years. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death associated with smoking. Based on 2016 and 2017 Behavioral Risk Factor Surveillance System (BRFSS) national survey data on 891,242 adult participants who indicated their smoking and vaping status, the cross-sectional association of vaping with self-reported COPD diagnosis was investigated, using univariable and multivariable weighted logistic regression models. Compared to never users, while dual users showed the highest association with self-reported COPD diagnosis (aOR=4.39, 95% CI: 3.98, 4.85), current vapers who were either ex-smokers or never smoked showed significantly higher association with self-reported COPD diagnosis (aOR= 3.24, 95% CI: 2.78, 3.78 and aOR=1.47, 95% CI: 1.01, 2.12, respectively). Current vapers who were ex-smokers showed higher association with self-reported COPD diagnosis than ex-smokers who do not vape (aOR=1.27, 95% CI: 1.09, 1.48). Dual users showed higher association with self-reported COPD diagnosis than current smokers who do not vape (aOR=1.16, 95% CI: 1.05, 1.27). Ex-smokers showed significantly less association with self-reported COPD diagnosis (aOR=0.67, 95% CI: 0.64, 0.71) than current smokers. Current vapers who were either ex-smokers or never smoked had less association with self-reported COPD diagnosis compared to current smokers, with aOR=0.85 (95% CI: 0.73, 0.99) and aOR=0.39 (95% CI: 0.27, 0.56). Vaping is significantly associated with self-reported COPD diagnosis in adults, even among vapers who never smoked. Whether there is a benefit for COPD of switching from smoking to vaping requires study of the long-term effects of vaping.